Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study

Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on... Graefes Arch Clin Exp Ophthalmol (2017) 255:1705–1712 DOI 10.1007/s00417-017-3702-1 RETINAL DISORDERS Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study 1 2 1 2 Masoud Soheilian & Saeed Karimi & Talieh Montahae & Homayoun Nikkhah & Seyed Aliasghar Mosavi Received: 23 October 2016 /Revised: 7 April 2017 /Accepted: 30 May 2017 /Published online: 14 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract = 0.101) in group B. Mean PRNFL thickness in group A Purpose To investigate the effects of intravitreal injection of decreased more than group B (P <0.001). bevacizumab (IVB) with or without anterior chamber Conclusion Conventional method of IVB injection was asso- paracentesis on intraocular pressure (IOP) and peripapillary ciated with acute IOP rise and significant PRNFL loss 3 retinal nerve fiber layer (PRNFL) thickness. months after injection. Anterior chamber paracentesis pre- Methods In this prospective randomized clinical trial, 90 eyes vents acute IOP rise and PRNFL loss. with center involving diabetic macular edema or wet type age- related macular degeneration (AMD) were randomly assigned . Keywords Peripapillary retinal nerve fiber layer thickness to receive IVB either without (group A) or with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study

Loading next page...
 
/lp/springer_journal/effects-of-intravitreal-injection-of-bevacizumab-with-or-without-2p03UXiBTm
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3702-1
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial